Startseite UR
![]() | Eine Stufe nach oben |
Lang, Siegmund
, Walter, Nike
, Neumann, Carsten, Bärtl, Susanne, Simon, Michaela, Ehrenschwender, Martin
, Hitzenbichler, Florian
, Alt, Volker
und Rupp, Markus
(2022)
Aktuelle Praxis der empirischen Antibiotikatherapie bei Spondylodiszitis.
Der Orthopäde.
Baertl, Susanne
, Walter, Nike
, Engelstaedter, Ulrike
, Ehrenschwender, Martin
, Hitzenbichler, Florian
, Alt, Volker
und Rupp, Markus
(2022)
What Is the Most Effective Empirical Antibiotic Treatment for Early, Delayed, and Late Fracture-Related Infections?
Antibiotics 11 (3), S. 287.
Rupp, Markus
, Baertl, Susanne, Walter, Nike
, Hitzenbichler, Florian
, Ehrenschwender, Martin
und Alt, Volker
(2021)
Is There a Difference in Microbiological Epidemiology and Effective Empiric Antimicrobial Therapy Comparing Fracture-Related Infection and Periprosthetic Joint Infection? A Retrospective Comparative Study.
Antibiotics 10 (8), S. 1-9.
Knoll, Gertrud und Ehrenschwender, Martin
(2021)
The non‐peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis.
FEBS Open Bio 11 (3), S. 714-723.
Ehrenschwender, Martin, Heimer, Sina, Knoll, Gertrud, Neubert, Patrick, Hammer, Karin P., Wagner, Stefan, Bauer, Richard J. und Jantsch, Jonathan
(2020)
Hypertonicity counteracts MCL 1 and renders BCL XL a synthetic lethal target in head and neck cancer.
The FEBS Journal.
Knoll, Gertrud, Riffelsberger, Petra, Raats, Danielle, Kranenburg, Onno und Ehrenschwender, Martin
(2020)
NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer.
Cell Death & Disease 11 (4), S. 1-11.
, Schuler-Thurner, Beatrice, Knoll, Gertrud und Ehrenschwender, Martin
(2018)
Hypertonicity primes malignant melanoma cells for apoptosis.
Apoptosis 23 (3-4), S. 201-209.
Volltext nicht vorhanden.
, Schuler-Thurner, Beatrice, Neubert, Patrick, Jantsch, Jonathan, Wajant, Harald und Ehrenschwender, Martin
(2018)
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors.
Oncogene 37 (30), S. 4122-4136.
Volltext nicht vorhanden.
(2018)
Hypertonicity-imposed BCL-XL addiction primes colorectal cancer cells for death.
Cancer Letters 435, S. 23-31.
Volltext nicht vorhanden.
und Wajant, Harald
(2018)
TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling.
Cell Death & Disease 9 (9).
Volltext nicht vorhanden.
(2017)
Death receptor 3 mediates necroptotic cell death.
Cellular and Molecular Life Sciences 74 (3), S. 543-554.
Volltext nicht vorhanden.
(2017)
Death receptor 3 signaling enhances proliferation of human regulatory T cells.
FEBS Letters 591 (8), S. 1187-1195.
Volltext nicht vorhanden.
und Wajant, Harald
(2016)
Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis.
Cell Death & Disease 7 (9), e2375-e2375.
Volltext nicht vorhanden.
Jantsch, Jonathan, Schatz, Valentin, Dettmer, Katja
, Dick, Christopher, Ehrenschwender, Martin
, Hellerbrand, Claus und Oefner, Peter J.
(2015)
Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen.
Cell Reports 2015 (13), S. 2048-2055.
und Ehrenschwender, Martin
(2015)
Soluble TL1A is sufficient for activation of death receptor 3.
FEBS Journal 283 (2), S. 323-336.
Volltext nicht vorhanden.
(2015)
p62 regulates CD40-mediated NFκB activation in macrophages through interaction with TRAF6.
Biochemical and Biophysical Research Communications 464 (1), S. 330-335.
Volltext nicht vorhanden.
Ehrenschwender, Martin
, Bittner, S., Seibold, K. und Wajant, Harald
(2014)
XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
Cell Death and Differentiation 2014 (5), e1570.
Klingeisen, Laura, Ehrenschwender, Martin
, Heigl, Ulrike, Wajant, Harald
, Hehlgans, Thomas, Schütze, Stefan und Schneider-Brachert, Wulf
(2012)
E3-14.7K Is Recruited to TNF-Receptor 1 and Blocks TNF Cytolysis Independent from Interaction with Optineurin.
PloS One 7, e38348.
und Ehrenschwender, Martin
(2012)
A 69-Year-Old Man with Long-standing Thrombocytopenia.
Clinical Chemistry 58 (5), S. 953-954.
Volltext nicht vorhanden.
, Brunner, Kirsten, Koessler, Juergen und Ehrenschwender, Martin
(2012)
A 77-Year-Old Man with a Prolonged Activated Partial Thromboplastin Time.
Clinical Chemistry 58 (10), S. 1402-1405.
Volltext nicht vorhanden.
, Kobsar, Anna und Brunner, Kirsten
(2012)
Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
Platelets 23 (8), S. 571-578.
Volltext nicht vorhanden.
Publikationsserver
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707